The present invention discloses functionalized nanomembranes, a method for preparation and their use. The functionalized nanomembrane comprises a) a first layer comprising a nanomaterial, b) a second layer comprising a biorepulsive material, the second layer being attached to at least one side of the first layer, and c) affinity groups, attached to the second layer.

A new strategy to design container molecules is presented. Sulfonylcalix[4]arenes, which are synthetic macrocyclic containers, are used as building blocks that are combined with various metal ions and tricarboxylate ligands to construct metal-organic super-containers (MOSCs). These MOSCs possess both endo and exo cavities and thus mimic the structure of viruses. The synthesis of MOSCs is highly modular, robust, and predictable.

Sorbent comprising a solid support material, the surface of which comprises first residues comprising a binuclear heteroaromatic structure comprising besides carbon atoms at least one of the heteroatoms N, O, S, and second residues comprising a mononuclear heteroaromatic structure comprising besides carbon atoms at least one of the heteroatoms N, O, S.

Methods and devices are disclosed for the treatment of a subject suffering from drug intoxication by cleansing a contaminated sample from the subject with adsorption media. The adsorption media composition is selected for its antithrombogenic properties and for its ability to adhere to one or more drug targets to be reduced or eliminated. The media can further be held in a cartridge for use in extracorporeal treatments such as those of hemoperfusion. Contacting the contaminated sample from the subject with the absorption medium allows for the separation of a portion of the drug target from the sample, producing a cleansed sample that can be infused into the subject.

The invention described herein teaches methods of removing microvesicular particles, which include but are not limited to exosomes, from the systemic circulation of a subject in need thereof with the goal of reversing antigen-specific and antigen-nonspecific immune suppression. Said microvesicular particles could be generated by host cells that have been reprogrammed by neoplastic tissue, or the neoplastic tissue itself. Compositions of matter, medical devices, and novel utilities of existing medical devices are disclosed.

In an example, a process of forming a photoisomerizing azobenzene polymer includes chemically reacting an azobenzene material that includes at least two chlorocarbonyl functional groups with an amine to form a photoisomerizing azobenzene polymer. The photoisomerizing azobenzene polymer has a polymer chain that includes a first chlorocarbonyl group disposed at a first end of the polymer chain, a plurality of repeating azobenzene monomer units, and a second chlorocarbonyl group disposed at a second end of the polymer chain.

In an example, a composition of matter includes a particle, a photoisomerizing polymer bonded to a first portion of the particle, and a chelating material bonded to a second portion of the particle.

A superpolar sorbent network is a sol-gel network of at least one metal oxide precursor condensed and at least one polyhydroxy molecule. The metal oxide precursor is a silicate precursor, aluminate precursor, titanate precursor, zirconate precursor, germinate precursor, or any combinations thereof, and the polyhydroxy molecule has a multiplicity of hydroxyl groups. The polyhydroxy molecule can be an organic molecule derived from nature. The superpolar sorbent network can be used as a particulate or bulk sorbent for sampling or removal of analytes or contaminants from an environment or can be coated on a tube or particulate substrate for use as a chromatographic stationary phase.

In an example, a process of forming a photoisomerizing azobenzene polymer includes chemically reacting an azobenzene material that includes at least two chlorocarbonyl functional groups with an amine to form a photoisomerizing azobenzene polymer. The photoisomerizing azobenzene polymer has a polymer chain that includes a first chlorocarbonyl group disposed at a first end of the polymer chain, a plurality of repeating azobenzene monomer units, and a second chlorocarbonyl group disposed at a second end of the polymer chain.

The present invention relates to development of stationary phases and preparation of extraction columns having substantially improved capacity (i.e., amount of material purified per single chromatographic run) for lab scale to industrial scale extraction chromatographic separation, from small scale to industrial scale, of rare earth elements (REEs) and the platinum group metals (PGMs). More specifically the invention relates to preparation of stationary phases and extraction columns for extraction of REEs or PGMs as a group from containing matrices of typical REE or PGM feedstock and separation and purification of individual REEs or PGMs from each other.